130 related articles for article (PubMed ID: 22880267)
1. [Quality of life is an important factor in the indication in patients with advanced pancreatic carcinoma--a prospective multicentric study].
Ryska M; Dusek L; Pohnán R; Bunganic B; Bieberová L; Ryska O; Lovecek M; Jon B; Rupert K; Krejcí M; Jarkovský J
Rozhl Chir; 2012 Apr; 91(4):199-208. PubMed ID: 22880267
[TBL] [Abstract][Full Text] [Related]
2. [Radical resection in patients with pancreatic head carcinomas. A retrospective survival analysis in a group of 307 subjects].
Ryska M; Strnad R; Belina F; Zavoral M; Sálek C; Hrabal P; Buric I; Lásziková E; Kvicerová H; Jurenka B; Holcátová I
Rozhl Chir; 2007 Aug; 86(8):432-9. PubMed ID: 17969981
[TBL] [Abstract][Full Text] [Related]
3. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses.
Schniewind B; Bestmann B; Kurdow R; Tepel J; Henne-Bruns D; Faendrich F; Kremer B; Kuechler T
Ann Surg Oncol; 2006 Nov; 13(11):1403-11. PubMed ID: 17009141
[TBL] [Abstract][Full Text] [Related]
4. Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenocarcinoma.
Nordby T; Ikdahl T; Bowitz Lothe IM; Fagerland MW; Heiberg T; Hauge T; Labori KJ; Buanes T
Pancreatology; 2013; 13(2):180-5. PubMed ID: 23561977
[TBL] [Abstract][Full Text] [Related]
5. [Radical procedures in patients with pancreatic cancer--impact on prolongation and quality of life].
Ryska M
Rozhl Chir; 2010 Dec; 89(12):725-30. PubMed ID: 21404511
[TBL] [Abstract][Full Text] [Related]
6. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
8. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors.
Nguyen TC; Sohn TA; Cameron JL; Lillemoe KD; Campbell KA; Coleman J; Sauter PK; Abrams RA; Hruban RH; Yeo CJ
J Gastrointest Surg; 2003 Jan; 7(1):1-9; discussion 9-11. PubMed ID: 12559179
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of pancreatic resection in advanced pancreatic cancer with special reference using hospital-free survival as a measure of quality of life.
Yasue M; Sakamoto J; Morimoto T; Yasui K; Kuno N; Kurimoto K; Teramukai S; Ohashi Y
Jpn J Clin Oncol; 1995 Apr; 25(2):37-45. PubMed ID: 7745821
[TBL] [Abstract][Full Text] [Related]
10. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
11. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
12. Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome study.
Hauser C; Patett C; von Schoenfels W; Heits N; Schafmayer C; Malchow B; Hampe J; Schniewind B; Becker T; Egberts JH
Dis Esophagus; 2015 Oct; 28(7):652-9. PubMed ID: 25059631
[TBL] [Abstract][Full Text] [Related]
13. Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer.
Strobel O; Berens V; Hinz U; Hartwig W; Hackert T; Bergmann F; Debus J; Jäger D; Büchler MW; Werner J
Surgery; 2012 Sep; 152(3 Suppl 1):S33-42. PubMed ID: 22770956
[TBL] [Abstract][Full Text] [Related]
14. [Long-term results after radical resections for pancreatic ductal adenocarcinoma--10 years experience].
Krejcí T; Leffler J; Poloucek P
Rozhl Chir; 2007 Apr; 86(4):174-9. PubMed ID: 17626458
[TBL] [Abstract][Full Text] [Related]
15. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients.
Li J; Chen X; Yang H; Wang X; Yuan D; Zeng Y; Wen T; Yan L; Li B
Postgrad Med J; 2011 Feb; 87(1024):89-95. PubMed ID: 21131612
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy.
Laitinen I; Sand J; Peromaa P; Nordback I; Laukkarinen J
Pancreatology; 2017; 17(3):445-450. PubMed ID: 28274687
[TBL] [Abstract][Full Text] [Related]
17. Palliative partial pancreaticoduodenectomy impairs quality of life compared to bypass surgery in patients with advanced adenocarcinoma of the pancreatic head.
Walter J; Nier A; Rose T; Egberts JH; Schafmayer C; Kuechler T; Broering DC; Schniewind B
Eur J Surg Oncol; 2011 Sep; 37(9):798-804. PubMed ID: 21767928
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
[TBL] [Abstract][Full Text] [Related]
19. Impact on quality of life after pancreatoduodenectomy: a prospective study comparing preoperative and postoperative scores.
Chan C; Franssen B; Domínguez I; Ramírez-Del Val A; Uscanga LF; Campuzano M
J Gastrointest Surg; 2012 Jul; 16(7):1341-6. PubMed ID: 22547348
[TBL] [Abstract][Full Text] [Related]
20. Effect of curative versus palliative surgical treatment for stage III pancreatic cancer patients.
Kymionis GD; Konstadoulakis MM; Leandros E; Manouras A; Apostolou A; Alexiou D; Katsaragakis S; Androulakis G
J R Coll Surg Edinb; 1999 Aug; 44(4):231-5. PubMed ID: 10453145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
